| Family Service Agency Of San Bernardino | |
|
11424 Chamberlaine Way Suite 11-12 Adelanto CA 92301-2869 | |
| (909) 886-6737 | |
| (909) 881-3871 |
| Full Name | Family Service Agency Of San Bernardino |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 11424 Chamberlaine Way, Adelanto, California |
| Authorized Official Name and Position | Patrice J Cormican (CEO) |
| Authorized Official Contact | 9098866737 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Family Service Agency Of San Bernardino 1669 N E St San Bernardino CA 92405-4405 Ph: (909) 886-6737 | Family Service Agency Of San Bernardino 11424 Chamberlaine Way Suite 11-12 Adelanto CA 92301-2869 Ph: (909) 886-6737 |
| NPI Number | 1245680735 |
|---|---|
| Provider Enumeration Date | 06/15/2016 |
| Last Update Date | 06/15/2016 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245680735 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
News Archive
Officials from the Dean McGee Eye Institute today announced the dedication of the Institute's new $46 million, five-story, 78,000-square-foot, world-class research and clinical facility.
Researchers at a trio of universities have found that reactivating a specific memory does not affect associated or related memories, adding to our understanding of how memories are stored and influenced.
The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration to expand the evaluation of Mirati's two investigational small molecules, potent and selective KRAS inhibitors - adagrasib (MRTX849), a G12C inhibitor in clinical development, and MRTX1133, a G12D inhibitor in preclinical development, as monotherapy and in combination with other agents - which target two of the most frequent KRAS mutations in cancer.
Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.
In this post in the Center for Global Development's "Global Health Policy" blog, William Savedoff, a senior fellow at the center, writes that while the World Bank has "spoken strongly" on the issue of raising tobacco taxes in an effort to "generate revenue, cut health costs and save lives," it "is moving forward cautiously if at all."
› Verified 1 days ago